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Early investigators  of the  coagulation of blood observed that  the dotting 
principle  which is formed during clotting disappears shortly after the clotting 
is accomplished  (1, 2). Blood thus possesses a mechanism not only to produce 
thrombin, but also to dispose of this substance after its role has been fulfilled. 
The acc~Jmulation of a  factor dangerous to the organism is prevented in this 
way. The nature of the antithrombic mechanism has been the subject of nu- 
merous investigations, ~  but it is still far from being fully understood. Astrup and 
Darling (4, 5) demonstrated that the antithrombic potency of plasma is bound 
to two distinct  factors:  (1)  the normal  antithrombin,  and  (2)  the  thrombin 
coinhibitor  activated  by heparin  to  thrombin  inhibitor.  According  to  these 
authors  the normal  antithrombin  is not affected by heparin  in any way. In 
the meantime Seegers and his associates (6-8) and Quick and Favre-Gilly (9) 
called attention to the fact that large amounts of thrombin are bound to the 
fibrin gel through an adsorptive process.  Seegers  (10)  later demonstrated the 
formation of a new antithrombic factor during the transformation of prothrom- 
bin into thrombin in a plasma in which all the antithrombic activity had been 
destroyed previously by shaking with ether. None of these antithrombic factors 
has  been isolated in  a  pure  form;  nor  has  their  mechanism  of action  been 
completely elucidated. 
It should be mentioned that with these reactions pronounced differences may 
be encountered with sera of different species. For example, according  to Howell 
(11) and Quick (12) in dog, cat, and rabbit sera, heparin greatly enhances the 
antithrombic potency, whereas Astmp and Darling (5) were unable to increase 
the antithrombic effect of bovine serum with heparin. Udvardy (13) described 
differences also in the type of thrombin inactivation curves and in the rate of 
the  inactivation  with  sera  of different  mammals. 
In the present paper investigations will be described on the thrombin-inacti- 
* This  work has been aided by a grant from the George Friedland  Foundation 
Fund. 
1  For ~letafled bibliography see Volkert's monograph (3). 
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vating capacity of human serum. Serum has been employed rather than plasma, 
in order to avoid the adsorptive inactivation,  dealing thus only with the true 
antithrombic components of serum. The emphasis has been laid on the rate of 
the  disappearance  rather  than  on the  amount of thrombin  inactivated,  most 
of the experiments being conducted with relatively small amounts of thrombin. 
Methods 
Human blood of healthy subjects was obtained by venipuncture with sterile dry 
syringes and then transferred to centrifuge tubes. The clot formed was gently pressed 
with a glass rod and the serum centrifuged, then left for an hour at room tempera- 
ture for the completion of the consumption of prothrombin (9)  and inactivation of 
thrombin. Serum not older than 24 hours was used in the experiments, except in the 
case in which  the  effect of storage upon the  thrombin-inactivating  factor was in- 
vestigated. 
Preparation of Thrombin.--For  the experiments related in this paper, bovine pro- 
thrombin was prepared according to Seegers  (14).  Prothrombin was converted into 
thrombin  either  with  human  brain  thromboplastin  in  the presence  of calcium,  or 
with sodium citrate  as described by Seegers  et al.  (15).  The purity of the product 
was of 150 to 300 NIH  ~ units per rag. of protein. There was no change in the activity 
of the concentrated solutions during a period of 1 month's storage in the refrigera- 
tor. 
Fibrinogen.--Bovine  fraction I, from Armour Laboratories, lot No.  128-163, was 
used without further purification. 
Commercial preparations of heparin sodium from Abbott Laboratories, protamine 
sulfate from Eli Lilly and Co., and crystalline soy bean antitrypsin from the Worth- 
ington Laboratories were employed. Toluidine blue 0, of 66 per cent dye content, 
was  obtained  from  Coleman and  Bell  Company.  All  the  other  chemicals  were  of 
reagent grade. 
Clotting Time  Determination.--Clotting  times  were  determined  with  a  method 
originally described  by Biirker  (16)  and  modified later  by Laki  (17).  Portions  of 
0.2 ml. each, of fibrinogen solution are pipetted  into the depressions of a  porcelain 
spot plate.  From a  serological  pipette 0.2  ml. of the solution to be tested is blown 
into  the fibrinogen solution, and  effective mixing is achieved by blowing a  current 
of air into the mixture. A  stop-watch is started  at the same time.  At regular time 
intervals  a  small glass hook is immersed in the solution, and  clotting time  is con- 
sidered  to be the time elapsed until  the first voluminous thread  can be withdrawn 
with  the hook. It was found that the most satisfactory results,  with regard  to the 
sharpness  of the end-point and  linearity of the plot of clotting time vs. thrombin 
dilution, were obtained with a  2 per cent bovine fraction I  solution in 0.2 ~r NaC1, 
0.05 x~ sodium phosphate buffer of pH 7.23. With the above method 1.5 NIH throm- 
bin units in 0.2 ml. of solution give a  clotting time of approximately 20 seconds at 
25  4- I°C. This clotting time was obtained consistently with freshly prepared fibrin- 
ogen solutions, but the clotting time prolonged with the aging of the solution. How- 
ever,  the fibrinogen solutions did not change their clotting ability in a  period  of 1 
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week, if kept in  the  frozen state at  -15°C.,  and incubated before use in  a  water 
bath of 36°C. for 10 minutes. 
Thr~nbitt Inactlvatitm  Test.--The method of Gerend~s  (18) was modified slightly. 
In a  pyrex test tube 0.8 ml. of serum was mixed with 0.2 ml. of 0.5  ~s phosphate 
buffer of pH 7.23 and sufficient saline solution  to give after the thrombin addition a 
final volume of 1.5 ml. The tube was placed in a constant temperature water bath 
at 24°C. and, after reaching the temperature equilibrium,  thrombin solution of the 
same temperature was added. At time intervals samples of 0.2 ml. were withdrawn 
and their clotting ability determined. The amount of thrombin used in these experi- 
ments varied between 30 and 40 units in 1.5 ml. of reaction mixture, which gave a 
clotting time of about 10 seconds with normal serum after an incubation of 30 sec- 
onds. The decrease  of the thrombin activity was usually followed for 6 minutes. 
Some experiments were conducted with thrombin concentrations ranging from 300 
to 600 units in the reaction mixture. 1 ml. of serum was mixed with 0.2 ml. of 0.5 
phosphate buffer of pH 7.23 and 1.0 ml. of thrombin solution,  and the mixture was 
incubated at 24 or 38°C. The samples of 0.2 ml. withdrawn at given time intervals 
were diluted 10 to 20 times before testing their thrombic activity. In some instances 
the 0.2 ml. samples were blown from a serological pipette into 4.8 ml. of fibrinogen 
solution,  the dilution being effected  in this way with the fibrinogen  solution itself, 
and the clotting time determined with the Klett-Summerson photoelectric colorim- 
eter as described  by Laki (17). 
RESULTS 
Kirtetiz,  s  of  the  Inactivation  of  Thrombin.--The  clotting  time  is  inversely 
proportional to the thrombin concentration  (19),  therefore: 
log Ct .= log a -  log (T/t) 
in which (Th) is the thrombin concentration, a  a proportionality constant, and 
Ct  the  clotting  time.  If the  disappearance  of  thrombin  follows  a  first  order 
kinetics, log (Th) plotted against reaction time should result in a  straight line, 
the negative slope of which is the rate constant, k: 
log  (T/t)  = log  (T/to)  -  kt 
As can  be seen  from the  above equation, a plot of  log  Ct  vs.  reaction time should 
result also in a  straight line, its slope equal to k.  Fig.  1 shows that with low 
thrombin concentration and different serum concentrations this relationship  is 
fulfilled, the reaction being thus of an apparent first order. Glazko and Ferguson 
(20), and Gerendts (18, 21) arrived at similar conclusions. In all the experiments 
performed with  thrombin concentrations  of the  order of 40  units per  ml.  of 
serum and  phosphate  buffer of pH  7.23  the  first  order  kinetics  was  strictly 
obeyed. Therefore, subsequently the rate of the thrombin inactivation will be 
expressed by the first order rate constant calculated with decimal logarithms, 
with time expressed in minutes. 
Increasing  the  thrombin  concentration  modifies  the  reaction  type.  With 142  THROMBIN  INACTIVATIOST BY HUMAN  SERUM 
thrombin concentrations of 300 to 600 units per 2.2 ml. of reaction mixture the 
reaction proceeds much more slowly, as is shown in Fig. 2, and not the loga- 
rithm, but the clotting time itself increases linearly with the incubation time. 
The slope of the straight lines decreases with increasing thrombin concentra- 
tion. 
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FIG. I. E~ect of  serum concentration on the rate  of  inactivation  of thrombin with 
40 units of thrombin in the reaction  mixture. The lines  correspond to 0, 20, 40, 60, 
80,  100 per cent serum concentration.  Ordinate,  log of clotting time; abscissa, in- 
cubation time. 
There was no evidence of an immediate disappearance of thrombin at the 
moment of mixing with serum, as chimed by Gerend~s (18, 21). The intercept 
of the lines of Fig. 1 with the ordinate corresponded exactly to the logarithm 
of the clotting time of a blank prepared in a paraffin-coated tube with physio- 
logical saline instead of serum. 
To a series of test tubes each containing 0.8 ml. of serum and 0.2 ml. of 05 x~ 
phosphate buffer of pH 7.23,  varying quantities of thrombin, from 25  to  100 
units, were added and the volume made up to 1.4 ml. with saline. The mixtures ELE~ER  MIH~LYI  143 
were incubated at 37°C. for an hour. At the end of this period practically no 
free thrombin was left in the solutions.  The mixtures were then placed in the 
24°C. water bath, and adding 30 units of thrombin the rate of the cl~-~ppearance 
of thrombin was determined. As can be seen  in Fig.  3,  the rate decreased 
linearly in the initial portion of the curve,  with the amount of thrombin in- 
activated in the first phase of the experiment.  This experiment  demonstrates 
that the antithrombic potency of serum is limited and can be  exhausted. 
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Fro. 2. Thrombin inactivation with  300  units  of thrombin per  ml.  of  serum. 
Curve A, serum alone; curve B, serum with 0.06 rag. of heparin per ml.; curve C, 
blank with physiological  saline. 
Serum inactivates thrombin at a lower rate than plasma.  This difference is 
explained readily on the basis of the preceding experiment.  Namely, in serum 
there will be less antithrombin available  for the exogenous thrombin than in 
plasma,  bemuse some of the antithrombic potency has, already been used to 
neutralize the  thrombin  generated  during  dotting. With small  amounts of 
thrombin  as  substrate,  Wilson  (22-24)  found  no  difference  between  the 
antithrombic effect of serum and plasma. However, his experiments with very 
dilute systems are likely to give erroneous results due to the pronounced spon- 
taneous inactivation of thrombin. Later, Owen  and Bollman  (25) reported 
significantly lower antithrombin values with serum than with plasma.  Seegers, 144  TtI_KOMBIN INACTIVATION BY HUMAN  SERUM 
Miller, Andres, and Murphy (26) could demonstrate that in equilibrium con- 
ditions, with high initial  thrombin concentration,  1 ml. of serum inactivates 
approximately 230 units of thrombin  less  than  the same amount of plasma; 
i.e., a  difference equal to the amount of thrombin generated and then inacti- 
vated during the clotting of blood. 
Stability  of tke Antitkrombic Factor.--The rate of the thrombin inactivation 
was determined with serum 2 hours after obtaining the blood and the deter- 
ruination was repeated daily for a period of 14 days. In this period of time the 
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FIG. 3.  Exhaustion of the antithrombic potency. The amounts of thrombin shown 
on  the abscissa  were  added  to serum  samples  and  after complete  inactivation of 
these,  the remaining  activity was  tested on a second thrombin addition. Ordinate, 
first order rate constant of the thrombin inactivation. Abscissa, amount of thrombin 
inactivated in the first phase of the experiment. 
serum was kept in a  refrigerator at +4°C.  A  slight decrease of about 5  to 10 
per cent was observed in the first 24 hours, but no further diminution of the 
activity was apparent in the period of time investigated. Also the activity of 
serum did not change during a period of 3 month's storage in the frozen state 
at  --15°C.  This result  is  in  accord with  the recent findings  of Seegers and 
associates (26). Stefanini (27), on the contrary, reported an increase in the anti- 
thrombic activity of plasma on storage. Probably this apparent activation was 
due to a shift of the pH of plasma during storage toward the pH optimum of the 
inactivation. 
The heat stability of the factor was investigated at pH 7.23.  A mixture of ELEMER MIH~LY!  145 
0.8 ml. serum, 0.2 ml., 0.5 M phosphate buffer, and 0.4 ml. of saline was heated 
for 5 minutes at different temperatures, then rapidly cooled. The activity of the 
heated sera was determined by adding 30 units of thrombin and following its 
disappearance. As can be seen in Fig. 4, the antithrombic factor is fairly stable 
for the period of 5 minutes below 58°C., but deteriorates rapidly above this 
temperature. 5 minutes of heating at 65°C.  destroys completely the activity 
(5,  12,  28). At  60°C.  the inactivation of the antithrombic factor followed a 
first order reaction course with k  =  3.5  X  10  -3  (calculated with natural loga- 
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FIG. 4.  Heat inactivation of the antithrombic factor.  Ordinate,  first order  rate 
constant of the thrombin inactivation.  Abscissa, temperature of the 3 minute heat- 
ing. 
rithms and time in seconds). From the heat inactivation an approximate energy 
of activation of 121,000 cal. can be calculated, a value suggesting the denatura- 
tion  of  a  large  protein  molecule. 
Effect of Variations in Tkrombin and Serum Concentration, pH, and Tempera- 
ture upon the Rate of Tkrombin Inactivation.--The  thrombin concentration was 
varied from approximately 7 to 28 units in  i.5 ml. of reaction mixture. This 
fourfold increase of the thrombin concentration caused a drop in the reaction 
rate of approximately 12 per cent. 
Varying the serum concentration by diluting it with 0.15  ~  NaC1  solution 
affects the rate  appreciably.  The  lines shown in  Fig.  1 were  obtained with 
serum concentrations of 0,  20, 40, 60, 80, and 100 per cent. There is a  slight 
inactivation of thrombin even in the absence of serum, caused by the absorption 146  T~O~IN  INACTIVATION BY HIYMAN  SERUM 
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FIG. 5.  The rate of the thrombin inactivation as a  function of pH. Ordinate, first 
order rate constant. Abscissa, pH. 
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FIG. 6.  Arrhenius plot  of  the  rate  constant of  thrombin inactivation. Ordinate, 
log of the first order constant. Abscissa, reciprocal of the absolute temperature. ELEMZER MI~LYI  147 
of thrombin on the glass surface,  as pointed out recently by several authors 
(29, 30,  25). The rate constant was proportional to the serum concentration 
(see also Quick (12)). Under the experimental conditions  described,  undiluted, 
normal human sera gave values of k ranging from 0.086 to 0.135, the average 
of 6 individual sera being 0.115. 
Serum samples were adjusted to different pH values with 0.1 N NaOH and 
0.1 N HCI, the pH of the mixtures being checked with the glass electrode.  No 
pH change occurred during the inactivation of thrombin. This procedure was 
used instead of adding buffers in order to avoid excessive pH differences in the 
second stage of the determination, pH control in the second stage showed that 
the pH of the fibrinogen solution after addition of the thrombin-serum mixture 
varied between 6.81 and 7.18, being thus in the range where clotting time is 
practically independent of pH.  Fig.  5 shows the pH dependence of the rate 
constant of the thrombin inactivation. A  clear maximum is apparent at pH 
8.5. 
A rise in temperature increases markedly the rate of the reaction. The Q10 is 
1.87 for the temperature range  10-20°C.  and 2.42 for the 20-30°C.  interval. 
Fig. 6 shows the Arrbenius plot of the data, log k plotted against 1/T. From the 
slope of the straight line an activation energy of 14,000 cal. can be calculated. 
This value is in agreement with that found earlier by Glazko and Ferguson (20) 
for the spontaneous inactivation of impure thrombin preparations. The low acti- 
vation energy certainly indicates that the process is not a protein denaturation. 
E~ect  of Some Added Reagents u~on the Rate of Thrombin Inacti~alion.-- 
Heparin.--Since  its discovery, heparin has been associated with the anti- 
thrombic potency of plasma,  but in spite of numerous investigations in this 
field, the problem is still far from being completely clarified. With small throm- 
bin concentrations the rate of inactivation by serum is tremendonsly increased 
by heparin in a  concentration of a few micrograms per milliliter  (21). Fig. 7 
shows the increase of the rate as a function of the heparin concentration, with 
30 units of thrombin as substrate. The first order character of the reaction is 
unaffected by heparin. Protamine sulfate and toluidine blue reverse the beparin 
effect completely. With protamine, as can be seen in Fig. 8, the effect of heparin 
is  completely neutralized when the  heparin-protamine weight ratio  is  1:1. 
Jaques, Charles, and Best (31) found a heparin-protamine ratio of 1:3 at the 
point of equivalence both in/~ ~ro and in in ~i¢o experiments, and Cowley and 
Lain (32) reported a ratio of 1:1 in in ~/~o experiments.  In the experiments of 
Portmann and Holden (33),  a  much higher ratio of 1:18  was  observed.  As 
pointed out by Best and Jaques (34), individual protamine preparations may 
show  widely differing  reactivity. Increasing the protamine concentration to 
fifty times the amount necessary to counteract the effect of 10 micrograms of 
heparin did not change further the rate of thrombin disappearance.  A slight 148  THROMBII~  II~ACTIVATION  BY  HUMAI~  SERUM 
decrease in the rate of inactivation was apparent only with concentrations of 
protamine of the order of 1 nag. per ml. However, this effect cannot be attributed 
to a  heparin-protamine antagonism. Protamine in high concentrations has a 
fibrinoplastic effect, accelerating the clotting of fihrinogen, and  through the 
increase of the reactivity of fibrinogen, it may reduce seemingly the rate  of 
the disappearance of thrombin. Therefore, shortening of the clotting time in 
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FIo. 7. Effect of heparin on the rate of thrombin destruction  by serum. Ordinate, 
rate constant. Abscissa, heparin concentration. 
the presence  of fairly high concentrations of protamine does not justify the 
conclusion of Tanturi and Wetzel (35)  on the presence of heparin in normal 
blood. 
The rate increase of the disappearance of thrombin caused by heparin can 
be suppressed at any time by adding protamine. As can be seen in Fig. 9, the 
thrombin inactivation after the addition of protamine proceeds at the same rate 
as in a blank experiment which contains neither heparin, nor protamine. 
Toluidine blue in an excess of 7.5 to 10 times over heparin, reduces the rate ET.~ER  ~IH~YI  149 
of the disappearance of thrombin to the level of the serum without heparin (36). 
However, contrary to the experience with prota:mlue, increasing  the] toluidine 
blue concentration over this value decreases  the rate further, below the value 
of the control.  This phenomenon is caused probably by the dotting-accelerat- 
ing effect of toluidine blue in higher concentrations,  described recently by Haley 
and  Rhodes (37).  In  these experiments  the rather  acidic  toluidine  blue was 
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FIG. 8. Heparin-protamine  antagonism.  Rate  constant  in  the  presence of  10 
micrograms of heparin  and  varying amounts  of protamine  sulfate in  the reaction 
mixture. Ordinate, rate constant. Abscissa, amount of protamine. 
carefully neutralized.  In general,  in all the experiments reported, the pH was 
controlled rigorously with the glass electrode. 
A quite unexpected result was encountered when the effect of heparin was 
tested on a system with high thrombin concentration. With 300 to 600 units of 
thrombin  as substrate heparin  proved to be ineffective  in  concentrations  of 
0.006, 0.06, and 0.6 nag. per ml. of reaction mixture. As is shown in Figure 2, 
the slope of the dotting time vs. incubation time plot is increased  somewhat by 
heparin, but this effect is caused by the slight prolongation of the dotting time 
by heparin in the second stage of the determination, and not by an acceleration 
of the thrombin destruction. When protamine was added to the samples before 
the dotting time determination,  the two curves had identical slopes. 150  THROMBIIV INACTIVATION  BY HUMAN SERUM 
Histamine.--Gerend~s, Csdk6, and Udvardy (38) claimed that histamine in 
moderate concentration strongly inhibits the thrombin inactivation by serum. 
In our hands, however, a fairly high histamine hydrochloride concentration of 
2.66 nag. per ml. did not affect the rate of thrombin disappearance with normal 
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FIo. 9.  The increased  rate caused  by heparin can be normalized by pro~mine at 
any time, and from then on the inactivation continues with the normal rate. Curve 
A, inactivation without heparin. Curve B, with 6 micrograms of heparin. Curves C 
to G, inactivation in the presence of the same amount of heparin as in curve B, with 
protamine addition after 20, 30, 50, 60, and 73 seconds respectively. As can be seen, 
the intersection of curves C to G with curve B  corresponds to the moment of the 
addition of prommine. Ordinate, log of clotting time. Abscissa, incubation time. 
serum, neither did it reduce  the heparin-induced  increase in rate.  Monkhous 
d  ~.  (39)  came to the same conclusion from in dro experiments. The assump- 
tion of a heparin-histamlne antagonism with respect to the thrombin inactiva- 
tion by serum, therefore, cannot be held. 
C~ium.--Calcium  chloride  in  0.02  M concentration  increased  the  rate  of ~L~sa m~  151 
thrombin inactivation by serum by 30 to 50 per cent. However, calcium is not 
indispensable  for  the  antithrombic  activity.  Serum  incubated  with  0.01 
potassium oxalate,  or sodium citrate, for a half an hour showed the same ac- 
tivity as an untreated blank. 
Heavy Meta~s.---O.O01 ~  copper sulfate did not change the rate of thrombin 
disappearance, whereas 0.001 ~ ferric nitrate slightly inhibited it. These experi- 
ments were performed in borate buffer of pH 8.5. Samples of serum were also 
incubated with several metal-binding reagents: 0.01 M potassium cyanide, or 
0.1 per cent sodium diethyldithiocarbamate,  did not affect the antithrombic 
activity. With cxar-dipyridyl in a final concentration of 0.1 per cent, a decrease 
in the thrombin disappearance rate of 27 per cent was observed, but in view of 
the findings  with the previous two reagents, this cannot be considered  as due 
to the removal of heavy metals. 
Adsorb/ng  Agcnts.--Serum  treated  with  several  adsorbing  agents:  barium 
sulfate, magnesium hydroxide, kaolin,  activated carbon, retained its thrombin- 
inactivating capacity unchanged. Similar findings were also reported by Seegers 
and associates (26). 
a-Tocopheryl Phospha/~.--Zierler,  Grob,  and  Lilienthal  (40)  and  Kay and 
Hutton (41) described an antithrombic effect of a-tocopheryl phosphate.  Ac- 
cording  to the latter authors, a complex is formed from fibrinogen,  tocopheryl 
phosphate, and calcium,  which is able to bind large amounts of thrombin. We 
found also that  the  disodium salt  of ~-tocopherol phosphoric  acid ester  s in 
concentrations higher  than 2 X  10  -4 ~  strongly inhibits the clotting of fibrin- 
ogen  with  thrombin,  but  that  the  progressive  inactivation  of thrombin  by 
serum was decreased rather than increased  by this reagent. With 2 X  10  -~ x~ 
concentration the decrease amounted to 38 per cent; with 4 X  10  -s ~  to 91 per 
cent of the value of the non-treated serum.  However, 0.02 M calcium chloride 
and 2  X10 -~ xt tocopheryl phosphate together slightly increased  the rate of 
inactivation of thrombin in borate buffer of pH 8.5. 
Ethyl Alcohol, Ethyl Etlwr, and Chloroform.raThe antithrombic  activity of 
serum is completely inhibited by 20 volume per cent alcohol  (42). This inhibi- 
tion is reversible.  Provided the contact with alcohol  was not too long, or the 
temperature  too  high,  the  whole  activity  returned  when  the  alcohol  was 
quickly dialyzed out. 
Shaking  the serum with  ether  or chloroform,  as previously mentioned  by 
some  authors  (43,  44),  completely  and  irreversibly  destroys  the  activity. 
Soy  Be~n Trypsin  Inhibitor.--The  rate  of  thrombin  disappearance  was 
practically  unaffected by soy bean  trypsin  inhibitor.  Since  plasmin  (serum 
tryptase) is strongly inhibited by the soy inhibitor (45), one may conclude that 
the destruction of thrombin in serum is not caused by plasmin.  This conclusion 
S  Kindly  supplied by Mr.  Parke  Richards,  Jr.,  of  Hoffmann-La  Roche,  Inc., 
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is supported also by the investigations of Glazko  (46) and Loomis eta/.  (47), 
who showed that  thrombin is stable in the presence  of plasmin. 
D/a/ys/s.--Prolonged dialysis against changes  of physiological saline solution 
does not affect the antithrombic factor of serum. 
DISCUSSION 
The  expressions,  antithrombin  and  antithrombic  potency, have been used 
rather indiscriminately  in the literature,  to designate any substance having a 
retarding effect upon the clotting of fibrinogen  with thrombin. The term anti- 
thrombin was reserved in the present paper to designate a  specific factor, or 
possibly factors, present in plasma and in serum capable of inactivating throm- 
bin.  The effect of antithrombin  is characterized  by a  progressive  destruction 
of thrombin, the process being irreversible.  Earlier authors (1, 2) claimed that 
thrombin inactivated by serum, the so called metathrombin, can be reactivated 
by different procedures.  However, we are unable to reactivate any thrombin 
using the different methods proposed for this purpose (1, 2, 48). 
As was clearly shown by Seegers and his associates  (26, 49, 50), the inactiva- 
tion of thrombin by serum or plasma leads to an apparent equilibrium  (irre- 
versible), dependent on both serum and thrombin concentration.  With small 
thrombin  concentrations  practically all  the thrombin  will  be destroyed, and 
in  this  case,  the reaction assumes an apparent first order course.  With high 
thrombin concentrations  the reaction proceeds slowly toward an equilibrium 
with appreciable quantities of thrombin remaining  in the active state. 
The role of heparin in thi¢ system deserves some consideration.  Heparin in 
the presence  of a cofactor inhibits the action of thrombin upon fibrinogen.  As 
pointed out by Klein and Seegers (8), this is a dynamic effect and it is not caused 
by a destruction of thrombin. It is quite distinct from the progressive and irre- 
versible inactivation of thrombin which takes place in serum. As demonstrated 
in the present paper, the latter process is also affected by heparin if the thrombin 
concentration in the system is relatively low, but heparin is ineffective  in the 
presence of high thrombin concentrations.  Whether the thrombin  preparation 
contained an inhibitor of the heparin which became effective with high thrombin 
concentrations  or  whether  some other  mechanism  was  involved,  cannot  be 
stated at the present time.  It is significant  that  Seegers and associates (26), 
using their most purified  thrombin preparations  in relatively high concentra- 
tion, also found the destruction of thrombin by serum unaffected by heparin. 
The effect of heparin  in the experiments with low thrombin concentration 
cannot be explained by an eventual cooperation of the normal antithrombin and 
heparin plus coinhibitor,  the latter having an apparent accelerating effect on 
the thrombin destruction by prolonging  the clotting time in the determination 
of the residual thrombic activity. By adding protamine to the fibrinogen  solu- 
tion, the effect of heparin mixed with the thrombin solution can be completely ~.LE~R  ~n~  153 
abolished. Nevertheless,  the rate of the thrombin disappearance  in the pres- 
ence of heparin was  the same whether the  fibrinogen  solution used for the 
dotting time determinations contained protamine or  not. One  may suppose 
that the  neutralization  of  heparin  by protamine  requires  time or that the 
serum proteins interfere with the neutralization. To exclude these possibilities, 
protamine was  added  after  serum,  heparin,  and  thrombin  had  been  incu- 
bated for different time intervals,  and the rate of disappearance  followed from 
then on. As can be seen in Fig. 9, the neutralization of heparin takes place in- 
stantaneously, with the return of the rate to that observed without heparin, but 
the curves are displaced proportionally with the amount of thrombin destroyed 
in the presence  of heparin.  Had the heparin only a  dynamic effect, all the 
curves should coincide with the curve obtained in the absence of heparin. 
The  rate  of  thrombin  disappearance  was  always  increased  by  heparin, 
though with individual sera the magnitude of the effect may have varied by as 
much as 30 per cent.  In the in dvo experiments  of Monkhous et a/.  (39), the 
parallelism  between  k and heparin concentration  was not evident, sometimes 
a  high heparin concentration being  associated  with a  normal or even low k 
value. This was observed with heparin released in anaphylactic shock and also 
with heparin injected intravenously. Possibly the heparin is released  partly in 
a bound form (51) and the injected heparin may also be bound to some plasma 
component  (52), which may explain the above discrepancy. 
From the investigations  on the effect of thrombin concentration,  pH, and 
temperature upon the rate of thrombin disappearance,  it is evident that these 
variables should be kept rigorously constant, whenever the rate determination 
is conducted for the purpose of estimating the concentration of the antithrombic 
factor. In the latter case the presence of heparin should also be excluded. 
su~x~y 
The inactivation of thrombin by serum follows a  first order  kinetics  with 
thrombin concentrations  of the order of 20 to 40 units per ml. of serum. With 
higher thrombin concentrations  of 300 to 600 units per ml. of serum, the rate 
slows down and not the logarithm of the clotting time, but the clotting time 
itself increases proportionally  with the incubation time. 
The antithrombic factor is stable  at -t-4°C. for a period of 2 weeks, or for 
3 months at --15°C. Heating over 58°C. destroys it rapidly. The heat inactiva- 
tion has an energy of activation of 121,000 cal. 
With low thrombin concentrations the rate of thrombin inactivation increases 
linearly with increasing serum concentration.  The pH optimum of the inacti- 
vation is at 8.5. Increasing  the temperature increases the rate. The energy of 
activation of the thrombin destruction by serum is 14,000 cal. 
Heparin increases the rate considerably  with low thrombin concentrations, 
but does not affect the rate with high thrombin concentrations.  The effect of 154  THROMBIN  I~qACTIVATIOI~  BY  HUMAN  SERUM: 
heparin can be abolished with protamlne or toluidine blue. Some other reagents 
were also tested with respect to their effect upon  the rate of inactivation of 
thrombin by serum. 
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